|Bid||77.03 x 1800|
|Ask||77.44 x 1100|
|Day's Range||75.00 - 86.43|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||127.50|
Since the early 1990s, Intel Corp. (INTC) has used the slogan “Intel Inside” to tell people to buy electronics powered by their semiconductors. The ads built strong brand recognition for a company whose product is hidden from view inside computers. The chip-maker’s marketing success clearly resonated with Adam Miron, the co-founder and chief brand officer at HEXO Corp. (HEXO.TO) He envisions the Gatineau, Que.-based cannabis producer infusing its products into household-name consumer goods from shampoos to snacks.
Ryan McQueeney and Maddy Johnson discuss earnings results from Netflix and the big U.S. banks. The hosts also remember the legacy of Jack Bogle and chat about several new cannabis industry deals.
HEXO Gets Approval to Be Listed on the NYSE AmericanHEXO On January 17, HEXO (HEXO) announced that it received approval to be listed on the NYSE (New York Stock Exchange) American. The stock will start trading under the ticker “HEXO” on January
Analysts' January Rating Updates for TLRY, CGC, and ACB(Continued from Prior Part)Canopy GrowthCanopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer for the company.
Analysts' January Rating Updates for TLRY, CGC, and ACB(Continued from Prior Part)Aurora Cannabis Aurora Cannabis (ACB) stock tanked nearly 8.2% after the market closed on January 16 due to the company’s announcement that it would raise ~$250
Given that diseases are becoming more difficult to treat, it would seem that we are in desperate need of major advancements in healthcare technology, and many of these steps forward have been made possible through the advent of legalized medical marijuana. Towards the tail-end of last year, Canadian Prime Minister Justin Trudeau and members of the Canadian government agreed to legalize recreational/medicinal cannabis usage, resulting in a rush of energy for Canada's cannabis industry. With the global medical marijuana market predicted to reach $55.0 billion by 2024, according to a new research study published by Global Market Insights, Inc, it stands to reason that companies with the ability to combine the complex medical applications of cannabis with integrative healthcare frameworks could create potential opportunities from entering the nascent marijuana industry.
Analysts' January Rating Updates for TLRY, CGC, and ACB(Continued from Prior Part)TilrayTilray (TLRY), one of the top cannabis players in Canada, has been a favorite of day traders. The company has experienced wild swings, giving a hard time to
ACB, TLRY, and APHA Are in the Red, but CGC Continues to GainCannabis stocks are falling Aurora Cannabis (ACB) was trading in the red as of 11:00 AM EST today after the company announced that it would be raising $250 million worth of capital through
Tilray Inc. (NASDAQ:TLRY) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are leading the cannabis industry. Is one a better bet right now?
Analysts' January Rating Updates for TLRY, CGC, and ACBThree major stocks With a lot of action expected to boost the sentiments of cannabis investors (HMMJ), three major cannabis stocks are off to a positive start in 2019. These three stocks are
Clean Spark, Inc. (CLSK) has the best in class microgrid solution for the cannabis industry. Today we are highlighting: CleanSpark, Inc. (CLSK), Aurora Cannabis, Inc. (ACB), Tilray, Inc. (NASDAQ: TLRY), Charlotte's Web Holdings, Inc. (CWBHF), and KushCo Holdings, Inc. (KSHB).
It’s one of the world’s fastest growing plants—a separate species of the cannabis sativa genus that, due to its 0.3% tetrahydrocannabinol (THC) content, makes it literally almost impossible to get high from smoking it. Just weeks ago, U.S. President Trump signed the 2018 Farm Bill into law. The newly revamped bill legalizes industrial hemp in the U.S., and in doing so not only makes hemp and CBD eligible for lucrative federal crop insurance, but also removes CBD from the Controlled Substances Act.